The EU agrees with CureVac to purchase 405 million doses of its vaccine and continues to negotiate with Moderna

Vaccines in Germany really feel discriminated in opposition to

There are common protests in Germany in opposition to elevating epidemiological measures to the federal degree, which the Berlin authorities needs to make management...

Pfizer Vaccine: Why will Europe vaccinate a month later than the UK?

The push of the British regulator to approve using the injection and the truth that the dominion was the primary to signal with Pfizer...

Queen Elizabeth II seeks a member for her private secretariat

Anybody all for growing their skilled expertise in relation to secretarial and protocol positions has a possibility to maneuver to London and begin working...

The European Fee is searching for methods to activate the restoration fund with out Poland and Hungary. What are the choices

In response to a senior EU official, quoted on Wednesday by EFE, Brussels has a number of choices on the desk for an answer...

On the threshold of 60,000 deaths from coronavirus, Italy is already getting ready an ‘spectacular’ vaccination plan

Via the EU, it's going to get 202 million doses from numerous corporations. You'll start vaccinating in late January and can culminate within...

The European Commission announced on Monday a new agreement for the acquisition of vaccines against Covid-19, in this case with the German pharmaceutical company CureVac for the purchase of up to 400 million doses when authorized, while continuing to negotiate with Moderna to seal a pact with the US firm.

The head of the Community Executive, Ursula von der Leyen, has assured in a statement without questions from the press that the agreement with CureVac will be authorized this Tuesday, so the signing will take place in the coming weeks.

The German has also said that Brussels continues to negotiate with the American company Moderna, which this Monday announced that its vaccine has an efficacy of 94.5%, as observed in the first analyzes.

The one with CureVac It is the fifth agreement that the European Commission closes for the acquisition of vaccines once proven to be safe and effective, following deals with AstraZeneca, Sanofi / GSK, Johnson & Johnson, and Pfizer / BioNTech. The first three are already signed, while the fourth has yet to be signed by both parties.

In addition, the community Executive reached a preliminary agreement with Moderna in August for the acquisition of 80 million doses of its vaccine and has “exploratory talks” with other firms.

“We do not know which vaccine will end up being safe and effective. The European Medicines Agency will authorize them after conducting a solid analysis, so we need to have a wide portfolio of vaccines based on different technologies “, explained Von der Leyen.



Related Articles